Publication:
The Performance of Critical Flicker Frequency on Determining of Neurocognitive Function Loss in Severe Obstructive Sleep Apnea Syndrome

dc.authorscopusid59620576800
dc.authorscopusid35291847600
dc.authorscopusid55854278100
dc.contributor.authorGüzel, A.
dc.contributor.authorGünbey, E.
dc.contributor.authorKöksal, N.
dc.date.accessioned2020-06-21T13:18:10Z
dc.date.available2020-06-21T13:18:10Z
dc.date.issued2017
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Güzel] Aygül, Department of Chest Diseases, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Günbey] Emre, Department of Otorhinolaryngology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Köksal] Nurhan, Department of Chest Diseases, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractThis study aimed to compare the critical flicker frequency (CFF) and the mail-in cognitive function screening ınstrument (MCFSI) tests’ effectiveness in diagnosing neurocognitive function losses in patients having severe obstructive sleep apnea syndrome (OSAS). A total of 85 subjects (47 patients with a diagnosis of severe OSAS and 38 healthy controls) were included into the study. MCFSI scores greater than or equal to five and CFF scores less than 39 Hz were considered abnormal. Demographic and polysomnographic parameters of patients with OSAS were studied, and correlations between the MCFSI, CFF scores and Epworth Sleepiness Scale (ESS) scores were analysed. The mean age of the patients was 49.6 ± 12.0 years. In the OSAS group, the CFF score was found to be low when compared with the control group, while the MCFSI score was found to be high. Pathological CFF scores (<39) were found in 13 patients (27.7%) in the OSAS group, while pathological MCFSI scores (≥5) were found in 19 patients (40.4%). CFF scores were found to be low in only 26% of the patients with OSAS who were found to have high MCFSI scores. MCFSI scores were high in only 38% of the patients with OSAS who were found to have low CFF scores. There was a significant correlation between ESS and CFF scores. In conclusion, the usefulness of the CFF test in determining cognitive function loss in patients with OSAS needs to be demonstrated via studies which utilize a larger sample size. © 2017 European Sleep Research Societyen_US
dc.identifier.doi10.1111/jsr.12531
dc.identifier.endpage656en_US
dc.identifier.issn0962-1105
dc.identifier.issn1365-2869
dc.identifier.issue5en_US
dc.identifier.pmid28382650
dc.identifier.scopus2-s2.0-85017410700
dc.identifier.scopusqualityQ1
dc.identifier.startpage651en_US
dc.identifier.urihttps://doi.org/10.1111/jsr.12531
dc.identifier.volume26en_US
dc.identifier.wosWOS:000412711800018
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherBlackwell Publishing Ltd customerservices@oxonblackwellpublishing.comen_US
dc.relation.ispartofJournal of Sleep Researchen_US
dc.relation.journalJournal of Sleep Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCritical Flicker Frequencyen_US
dc.subjectHypoxiaen_US
dc.subjectNeurocognitiveen_US
dc.subjectSleep Apneaen_US
dc.titleThe Performance of Critical Flicker Frequency on Determining of Neurocognitive Function Loss in Severe Obstructive Sleep Apnea Syndromeen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files